Dr Aqua Asif
Urologist
Dr Asif is a doctor in urology with a strong research track record.
She will join UCL/UCLH as an NIHR Academic Clinical Fellow in 2025.
Her work targets better prostate MRI quality and access across health systems.
She contributes to trials improving scan quality and patient pathways.
She is active in medical education and curriculum development
Education and qualifications
Awards and highlights
- British Association of Urological Surgeons.
- BAUS Section of Oncology.
- Royal College of Surgeons of England.
- British Medical Association.
Awards and highlights
- Royal Surrey news feature on PRIME/GLIMPSE and MRI quality impact.
- EAU 2023 Best Abstract by Resident (GLIMPSE team).
- Royal Surrey Clinical Audit Day — First Prize (2023).
At a glance
- Current: NIHR Academic Clinical Fellow (Urology), UCL / UCLH (from Oct 2025).
- Honorary roles: UCL Division of Surgery & Interventional Science.
- Previous: Royal Surrey NHS Foundation Trust, research and education.
- Degrees: MBChB (Leicester, 2017).
- Memberships/awards: MRCS (2024), FHEA, MAcadMEd.
- Research focus: Prostate MRI quality and access; urology education.
Expertise
Profiles and links
- MBChB, University of Leicester (2017).
- MRCS, Royal College of Surgeons of England (2024).
- BSc, PGCert (medical education focus).
- FHEA, MAcadMEd.
Profiles and links
- ResearchGate: researchgate.net/profile/Aqua-Asif
- ASiT elected member page: asit.org › Elected Members
- Royal Surrey news: royalsurrey.nhs.uk › News
- ORCID/Scholar profiles if available.
Research and publications
- Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME) — trial protocol. BMJ Open. 2023. DOI: 10.1136/bmjopen-2022-070280.
- Global variation in MRI quality of the prostate: PRIME quality control phase using PI-QUAL. Radiology. 2023. (Royal Surrey summary confirms scale and impact.)
- The LANDMARK project: summaries of key papers shaping urology. BJU International. 2024. DOI: 10.1111/bju.16548.
- PRIME Diagnostic Clinical Trial: Biparametric vs multiparametric MRI. JAMA. 2025. (Forthcoming/early view on ResearchGate.)
Learn more about Focal Therapy and Prostate Cancer
Financial Support for Prostate Cancer You Can Claim in 2025
Reading time: 7 minutes Author: Focal Therapy Medical Team Medically reviewed by Dr Aqua Asif...
Finding the Next Available Prostate Cancer Treatment Slot
Author: Focal Therapy Clinic Medical team Length of read: ±7 minutes Publish date: January 10...
A Guide to Targeted Therapy Drugs for Prostate Cancer
Reading time: 12 minutes Author: Focal Therapy Medical Team Medically reviewed by Dr Christos Mikropolous...
Any questions?
If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.
Contact the team
Subscribe to our newsletter
Get expert advice & the latest prostate cancer research - straight to your inbox.
We care about your data in our privacy policy.
